PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients

In the early days of the COVID-19 pandemic, multiple studies indicated that patients with Lung Cancer (LC) were at higher risk of having complications from SARS-CoV-2 infection. Here, we sought to determine whether they remain at higher risk post-vaccination in the frequency and severity of breakthrough infections.